NB

Nathan Boersen

SP Signal Pharmaceuticals: 3 patents #1 of 56Top 2%
BS Bristol-Myers Squibb: 1 patents #180 of 513Top 40%
📍 Summit, NJ: #6 of 65 inventorsTop 10%
🗺 New Jersey: #424 of 6,523 inventorsTop 7%
Overall (2018): #38,838 of 503,207Top 8%
4
Patents 2018

Issued Patents 2018

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
10131639 Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methylcyclohexylamino)-pyrimidine-5-carboxamide Indrajit Ghosh, Lianfeng Huang, Daozhong Zou 2018-11-20
10052322 Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one Anil Menon, Darshan Parikh, Dora Visky, Thomas Lee, Xiaozhang Liang 2018-08-21
9981971 Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one as TOR kinase inhibitors 2018-05-29
9884042 Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide Wai Yip Thomas Lee, Ho-Wah Hui, Paul Kurtulik 2018-02-06